Navigation Links
Advanced Life Sciences Announces Successful Thorough QT Study of Cethromycin
Date:2/19/2008

velopment, members of the management and scientific teams will be present at the upcoming FDA Anti-Infectives Advisory Committee meeting discussing non-inferiority margins in CAP clinical trials scheduled for April 1 and 2, 2008 in Maryland. The Company will hold an investor conference call on April 3, 2008 after the completion of the FDA Anti-Infectives Advisory Committee to provide management's viewpoints and reflections on the deliberations.

In an effort to re-confirm the regulatory pathway for cethromycin in CAP after the Anti-Infectives Advisory Committee meeting is completed, Advanced Life Sciences has requested and established a meeting on April 7, 2008 with the FDA to discuss the anticipated NDA submission in CAP. The Company will conduct a conference call with investors on April 10, 2008 to discuss the outcome of the April 7th meeting with the FDA.

Summary of Upcoming Events:

-- April 3 -- conference call to provide management's understanding of

and reflections on the discussions of the FDA

Anti-Infectives Advisory Committee meeting

-- April 10 -- conference call to discuss the outcome of the Company's

one-on-one meeting with the FDA

The Company will issue a press release with the time and dialing instructions for each call in advance.

Conference Call Details:

The Company is hosting a conference call and live webcast today at 10:00 a.m. ET to discuss Fourth Quarter and Full Year 2007 Financial Results along with the contents of this press release.

The conference call will be webcast simultaneously over the Internet. Please visit the Investor Relations section of Advanced Life Sciences' corporate website http://www.advancedlifesciences.com. Alternatively, callers may participate in the conference call by dialing 888-713-4215 (domestic) or 617-213-4867 (international). Th
'/>"/>

SOURCE Advanced Life Sciences Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
3. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
4. Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
5. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
6. Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma
7. Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
8. ECLIPSE Data on Effects of Otsukas Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients Hemodynamics and Urine Output Featured in Heart Failure Society of Americas Late Breaking Trials
9. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
10. Avastin Achieves Impressive Rate of Curative Surgery in Patients with Advanced Colorectal Cancer
11. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... VIEJO , Kalifornien, 20. Mai 2013 ... bekannt, dass das Unternehmen die CE-Kennzeichnung für ... zur Embolisation von Aneurysmen erhalten hat. Das ... Europa bereits mit der kontrollierten Einführung dieser ... bietet die SL-Produktfamilie auch ein verbessertes Handling, ...
(Date:5/20/2013)... LONDON , BERLIN ... 2013 Arthroscopy Devices Market ... Preference for Minimally Invasive Procedures to Drive Future Growth" ... trends for the six arthroscopy device market segments: arthroscopes, ... arthroscopy radio frequency systems, and arthroscopy visualization systems. The ...
(Date:5/20/2013)... 2013  Neuralstem, Inc. (NYSE MKT: CUR) today reported ... principal investigator, presented updated Phase I data from its ... the treatment of amyotrophic lateral sclerosis (ALS or ... diabetes special medical symposium in Bucharest, Romania ... Therapeutic Advances in Stem Cell Therapy," Dr. Feldman outlined ...
Breaking Medicine Technology:Sequent Medical, Inc. bringt neue SL-Produktfamilie seiner WEB Geräte zur Embolisation von Aneurysmen auf den Markt 2Sequent Medical, Inc. bringt neue SL-Produktfamilie seiner WEB Geräte zur Embolisation von Aneurysmen auf den Markt 3Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth 2Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth 3Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth 4Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 2Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 3Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 4
(Date:5/20/2013)... Wolters Kluwer Health is pleased to ... published journals won 13 ASHPE awards in 10 ... and publications for editorial, design, print and online ... be recognized year after year for delivering high-quality ... with quality, depth, and impact," said Jayne Marks, ...
(Date:5/20/2013)... May 20, 2013 Join Seva Foundation in ... at the Palace of Fine Arts Theater in ... , C.C. White and Shimshai, with host Wavy Gravy. All ... world. , Reserved seats are $40 & $55, ... the artists and a front row seat at the show. ...
(Date:5/20/2013)... HealthEconomics.Com , the global leader ... present a new breakthrough in digital marketing and communications ... the reach of traditional, real-world trade shows and conferences ... feel, and benefits of a physical trade show, but ... hours a day, seven days a week, and three ...
(Date:5/20/2013)... 2013 A new Benefits of Pharmacy ... the creators of the MedEx Pack announced. ... Pharmacy Home Delivery, in order to provide useful details for ... handled. Clyde Furuta, MedEx Direct owner and pharmacist said, ... that with a product like the MedEx Pack, patients can ...
(Date:5/20/2013)... Fresno, CA (PRWEB) May 20, 2013 It’s ... a chance, there’s still time to bust out those dusty ... going to have a little cross-company challenge in the office ... to see who can log the most pledged miles for ... building, but they’ll never share their miles! , *insert battle ...
Breaking Medicine News(10 mins):Health News:Wolters Kluwer Health receives 13 awards from the ASHPE 2Health News:Memorial Day Kirtan Concert Palace of Fine Arts Theater in San Francisco Featuring: Snatam Kaur, Jai Uttal, C.C. White & Shimshai with host Wavy Gravy,May 27th 7:00 PM 2Health News:HealthEconomics.Com Launches HE-Xpo, an Online Virtual Trade Show, Educational Center and Exhibit Hall at Major Pharmaceutical Industry Meeting 2Health News:HealthEconomics.Com Launches HE-Xpo, an Online Virtual Trade Show, Educational Center and Exhibit Hall at Major Pharmaceutical Industry Meeting 3Health News:Benefits of Pharmacy Home Delivery Report Published by MedEx Direct 2
... Quad Will Become the Highest-Selling Antiretroviral in the ... from Decision ResourcesWALTHAM, Mass., May 19 Decision ... advisory firms for pharmaceutical and healthcare issues, finds ... six percent annual growth in the HIV drug ...
... ( www.apieron.com ) significantly strengthened its senior ... Vice President, Sales & Marketing, and Bryan Miller as ... Bubrick has more than 20 years of operational and ... in diabetes management. Prior to joining Apieron, Mr. Bubrick ...
... May 19 New Life Agency filed suit against ... contract.This lawsuit grew out of a previous contractual relationship ... in December 2005. Once New Life Agency assumed direct ... for New Life,s Surrogate Maternity and Cycle Medical Plan(R), ...
... Has 6 Front Range LocationsDENVER, May 19 Clinic ... Solutions, announced today the firm has secured an agreement ... to all Front Range MedExpress Urgent Care locations. ... nationwide reach."This is a key new contract for us," ...
... INTERESTS ARE NOT ALIGNED WITH STOCKHOLDERSADVOCAT BOARD NEEDS TO ... May 19 Bristol Investment Fund, Ltd. ("Bristol") announced ... stockholders of Advocat, Inc. (the "Company") (Nasdaq: ... qualified and independent director nominees, Paul Kessler and Richard ...
... be Issued from Among Intradigm,s Large Collection of ... Intradigm Corporation, a leading developer of targeted, ... issuance of United States patent 7,534,878, titled "Composition ... Cancer and Other Neovascularization Diseases." The issued ...
Cached Medicine News:Health News:Sales of Antiretroviral Agents Will Drive Substantial Six Percent Annual Growth in the HIV Drug Market Through 2013 2Health News:Sales of Antiretroviral Agents Will Drive Substantial Six Percent Annual Growth in the HIV Drug Market Through 2013 3Health News:Apieron Strengthens Senior Leadership With Commercial, Financial Appointments 2Health News:New Life Agency, Inc. Continues to Trial Against Beitler Services, Inc. in Pursuit of Payments for Surrogate Maternity Claims 2Health News:New Life Agency, Inc. Continues to Trial Against Beitler Services, Inc. in Pursuit of Payments for Surrogate Maternity Claims 3Health News:Clinic Service Announces Agreement to Provide Billing Service to MedExpress 2Health News:Support Bristol's Highly Qualified Independent Nominees for Advocat Board 2Health News:Support Bristol's Highly Qualified Independent Nominees for Advocat Board 3Health News:Support Bristol's Highly Qualified Independent Nominees for Advocat Board 4Health News:Support Bristol's Highly Qualified Independent Nominees for Advocat Board 5Health News:Support Bristol's Highly Qualified Independent Nominees for Advocat Board 6Health News:Support Bristol's Highly Qualified Independent Nominees for Advocat Board 7Health News:Support Bristol's Highly Qualified Independent Nominees for Advocat Board 8Health News:Support Bristol's Highly Qualified Independent Nominees for Advocat Board 9Health News:Intradigm Announces Issuance of RNA Interference (RNAi) Patent Covering Potent siRNA Sequence 2Health News:Intradigm Announces Issuance of RNA Interference (RNAi) Patent Covering Potent siRNA Sequence 3
... Eppendorf Mastercycler Family offers fast temperature control, ... optimal flexibility. Personal cards enable safe program ... transfer of individual protocols between different Mastercyclers. ... PCR and come with a two-year warranty. ...
... The latest addition to ... thermal cyclers is the personal-sized ... ideal instrument for both basic ... It represents the culmination of ...
... well thermocycler with unique High ... for fastest available heating and ... with High Pressure Lid for ... Includes motorized lid for ...
... highest precision, more user-friendliness and absolute reliability ... the definition of the Mastercycler ep system. ... research has been developing dynamically. The same ... Systems. To keep pace with these ...
Medicine Products: